An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Clinical trial NCT07236762 · RECRUITING

Trial details

NCT number: NCT07236762
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Lupus Nephritis (LN)Sjogren's Syndrome Inflammatory Myopathy Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Antiphospholipid Syndrome

Start date: 2025-11-24
Primary completion: 2026-11-24
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.